World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
11381
World Ranking
13242
National Ranking
5639

Michael A. McDevitt publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Michael A. McDevitt sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 158 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Michael A. McDevitt D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael A. McDevitt sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Michael A. McDevitt is affiliated with Johns Hopkins University in the United States and works at the intersection of medicine and social sciences. Their research spans medicine with a focus on oncology and communication-related fields, including political science and international relations. They have contributed to both biomedical and social scientific literature.

McDevitt's main fields of study include:

  • Medicine
  • Social Sciences

Their research extends into several subfields such as oncology, communication, political science and international relations, radiology, nuclear medicine and imaging, as well as sociology and political science.

  • Oncology
  • Communication
  • Political Science and International Relations
  • Radiology, Nuclear Medicine and Imaging
  • Sociology and Political Science

Michael A. McDevitt's work covers a range of topics, blending medical research with media and political studies. These topics include:

  • Monoclonal and Polyclonal Antibodies Research
  • Social Media and Politics
  • Media Studies and Communication
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Populism, Right-Wing Movements

Among their recently published papers where they are an author are:

  • "Journalism and Democratic Backsliding: Critical Realism as a Diagnostic and Prescription for Reform," 2022, Political Communication
  • "An Overdue Contribution: Mass Communication Theory in the Security of Democracy," 2022, Mass Communication & Society

The broader collection of recent papers connected to their research environment includes studies in cancer immunotherapy and clinical oncology, such as:

  • "Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors," 2021, Journal for ImmunoTherapy of Cancer
  • "Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat," 2020, Haematologica
  • "A phase I study of CD40 agonist ABBV-927 plus OX40 agonist ABBV-368 with or without the PD-1 inhibitor budigalimab in patients with advanced solid tumors," 2020, Journal of Clinical Oncology

Frequent collaborators in Michael A. McDevitt's work include:

  • William R. Henner
  • Hua Fang
  • Maulik Patel
  • Joel S. Hayflick
  • Martha Blaney

Michael A. McDevitt has published in several venues, with multiple works appearing in Blood and Cancer Research, along with contributions to journals focused on immunotherapy, political communication, and mass communication.

  • Blood
  • Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • Political Communication
  • Mass Communication & Society

In addition to articles, McDevitt has authored at least one book published by Oxford University Press titled Where Ideas Go to Die (2020), addressing themes intersecting media and communication.

Best Publications

  • Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

    Joshua Wechsler;Marianne Greene;Michael A. McDevitt;John Anastasi

  • A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development

    Ramesh A. Shivdasani;Yuko Fujiwara;Yuko Fujiwara;Yuko Fujiwara;Michael A. McDevitt;Stuart H. Orkin

  • Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

    Anna M. Jankowska;Hadrian Szpurka;Ramon V. Tiu;Hideki Makishima

  • 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies

    Andrew J Dunbar;Lukasz P Gondek;Christine L O'Keefe;Hideki Makishima

  • Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A

    Anna M. Jankowska;Hideki Makishima;Ramon V. Tiu;Hadrian Szpurka

  • Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

    Shannon R. McCurdy;Jennifer A. Kanakry;Margaret M. Showel;Hua Ling Tsai

  • Somatic SETBP1 mutations in myeloid malignancies

    Hideki Makishima;Kenichi Yoshida;Nhu Nguyen;Bartlomiej Przychodzen

  • Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.

    Jason E. Farrar;Michelle Nater;Emi Caywood;Michael A. McDevitt

  • Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

    Yvette L. Kasamon;Javier Bolaños-Meade;Gabrielle T. Prince;Hua Ling Tsai

  • Requirement of a downstream sequence for generation of a poly(A) addition site

    Michael A. McDevitt;Michael J. Imperiale;Haseeb Ali;Joseph R. Nevins

  • A “knockdown” mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1

    Michael A. McDevitt;Ramesh A. Shivdasani;Yuko Fujiwara;Yuko Fujiwara;Haidi Yang

  • Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo

    Jonathan K. Alder;Robert W. Georgantas;Richard L. Hildreth;Ian M. Kaplan

  • Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies

    Christine O'Keefe;Michael A. McDevitt;Jaroslaw P. Maciejewski

  • Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies

    Hideki Makishima;Heather Cazzolli;Hadrian Szpurka;Andrew Dunbar

  • Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.

    Ramon V. Tiu;Lukasz P. Gondek;Christine L. O'Keefe;Paul Elson

  • Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.

    Hideki Makishima;A M Jankowska;R V Tiu;Hadrian Szpurka

  • Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

    Christopher G. Kanakry;Hua Ling Tsai;Javier Bolaños-Meade;B. Douglas Smith

  • Sequences capable of restoring poly(A) site function define two distinct downstream elements.

    M.A. McDevitt;R.P. Hart;W.W. Wong;J.R. Nevins

  • Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia

    Gabriela M. Baerlocher;Elisabeth Oppliger Leibundgut;Oliver G. Ottmann;Gary Spitzer

  • CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

    Hideki Makishima;Anna M. Jankowska;Michael A. McDevitt;Christine O'Keefe

Frequent Co-Authors

Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski Cleveland Clinic
Mikkael A. Sekeres
Mikkael A. Sekeres Cleveland Clinic
Judith E. Karp
Judith E. Karp Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Mark J. Levis
Mark J. Levis Johns Hopkins University
James G. Herman
James G. Herman University of Pittsburgh
Alan F. List
Alan F. List Precision BioSciences
Richard J. Jones
Richard J. Jones Johns Hopkins University
Ghulam J. Mufti
Ghulam J. Mufti King's College London
Seishi Ogawa
Seishi Ogawa Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA opens the door to diverse careers. Many students expand their options through related fields that blend lab science with health information, coding, or nutrition.

Medical coding and billing is a popular path for those who wish to combine healthcare with technology. If you are curious about medical coding jobs salary, you’ll find steady demand and good earning potential, especially as healthcare records move toward digitization. However, it’s important to consider the work-life balance and daily job duties before deciding if is medical billing and coding worth it.

Another growing field is Health Information Management. Pursuing an him degree online is an affordable and flexible way to enter a data-focused healthcare career. If your biology background leans toward nutritional science, a nutrition masters online can also offer rewarding professional opportunities in wellness, education, or clinical practice.

These degree pathways can align perfectly with a foundation in Biology or Biochemistry, opening doors to both hands-on and analytical careers in the expanding health and science sectors.

Best Scientists Citing Michael A. McDevitt

Trending Scientists

Recently Published Articles